Small clinical trials of exenatide and liraglutide in people with Parkinsons disease have shown improvements in motor symptoms, emotional wellbeing, activities of daily living and quality of life
The next generation of weight loss peptides continues to expand the options available to women who need effective weight management without sacrificing sexual health
Firstly, this may result from direct PCE of retatrutide on the human cardiac sinus node via GCGR and/or GIPR and/or GLP1-R
Lilly runs tirzepatide and orforglipron and now retatrutide
For research, measuring both is often ideal
Patients and clinicians planning for retatrutide access in 2026 should begin now to frame it within a comprehensive metabolic health program that includes resistance exercise to preserve lean muscle mass during weight loss, protein optimization to mitigate sarcopenia risk, and regular monitoring of body composition rather than body weight alone